| Serial Number | 79377825 |
| Word Mark | Y VECTORY THERAPEUTICS |
| Filing Date | Thursday, July 20, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, September 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the stacked wording "VECTORY THERAPEUTICS" in stylized dark blue lettering to the right of an incomplete circle comprised of green, light blue, and dark blue segments; inside this incomplete circle is a block letter "Y" comprised of green, light blue, and dark blue segments. |
| Goods and Services | Viral systems, gene therapy systems, nucleic acid delivery systems, namely viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neurodegenerative disease; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy; clinical medical reagents for use in gene therapy; pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in gene therapy |
| Indication of Colors claimed | The color(s) blue and green is/are claimed as a feature of the mark. |
| Goods and Services | Gene and nucleic acid delivery by viral vectors, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics |
| NOT AVAILABLE | THERAPEUTICS |
| Goods and Services | Research, product development and consultancy in the field of biotechnology, biologics and medical science; research and product development in the field of pharmaceutics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 7, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 7, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 7, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VectorY B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Event Date | Event Description |
| Thursday, August 31, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, September 7, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 12, 2023 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 6, 2024 | ASSIGNED TO EXAMINER |
| Saturday, March 9, 2024 | NON-FINAL ACTION WRITTEN |
| Sunday, March 10, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, March 28, 2024 | REFUSAL PROCESSED BY MPU |
| Friday, September 27, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 27, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 27, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 24, 2024 | REFUSAL PROCESSED BY IB |
| Friday, March 29, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |